Add Company
Join Now

Thymmune Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Thymmune Therapeutics's estimated annual revenue is currently $1.6M per year.(i)
  • Thymmune Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Thymmune Therapeutics has 20 Employees.(i)
  • Thymmune Therapeutics grew their employee count by 67% last year.

Thymmune Therapeutics's People

NameTitleEmail/Phone
1
CEO & FounderReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Senior ScientistReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Senior Research Associate IReveal Email/Phone
6
Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Thymmune Therapeutics?

Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell therapy products addressing significant opportunities with unmet clinical need across immunology. Building on work from leading labs, Thymmune has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$1.6M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M20-9%$69M
#2
$2.9M20N/AN/A
#3
$1.5M20-47%N/A
#4
$3.1M2011%N/A
#5
$2M20-13%N/A